Don D Sin Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

06/2008	Biomarkers in COPD: are we there yet?
06/2008	The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
01/2008	Interleukin-6: a red herring or a real catch in COPD?
09/2007	Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology.
07/2007	The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.
03/2007	Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
03/2007	A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
01/2007	Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD.
01/2007	Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
09/2006	Cooling the fire within: inhaled corticosteroids and cardiovascular mortality in COPD.
09/2006	Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
01/2006	Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
01/2005	Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.
01/2005	Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
01/2005	Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis.
10/2004	Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
01/2004	Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
07/2003	Inhaled glucocorticoids in COPD: immortal time bias.
01/2003	Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.
07/2002	The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.

Articles by Research Topic

Disease

20	Chronic Obstructive Pulmonary Disease (COPD) 06/2008 - 07/2002
4	Inflammation 06/2008 - 10/2004
3	Lung Neoplasms (Lung Cancer) 09/2008 - 03/2006
2	Pneumonia (Pneumonitis) 07/2008 - 02/2005
2	Obstructive Sleep Apnea 11/2002 - 02/2002
1	Myocardial Infarction 01/2007
1	Asthma (Bronchial Asthma) 07/2003

Drug/Important Bio-Agent (IBA)

8	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2007 - 07/2002
3	fluticasone (Cutivate)FDA LinkGeneric 06/2008 - 10/2004
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 09/2008 - 01/2007
2	salmeterol (Serevent)FDA Link 06/2008 - 01/2006
2	Biological Markers (Surrogate Marker)IBA 06/2008 - 06/2008
1	Particulate MatterIBA 07/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	SmokeIBA 07/2007
1	SteroidsIBA 03/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2007
1	C-Reactive ProteinIBA 03/2006
1	Carbon DioxideIBA 02/2005
1	UniversalIBA 07/2003
1	GlucocorticoidsIBA 07/2003

Therapy/Procedure

2	Continuous Positive Airway Pressure 11/2002 - 02/2002
1	Pneumonectomy (Lung Volume Reduction) 09/2007
1	Artificial Respiration (Mechanical Ventilation) 01/2007
1	Drug Therapy (Chemotherapy) 09/2006